Vertex-Logo.jpg
Vertex Announces First Quarter 2024 Financial Results
May 08, 2024 07:02 ET | Vertex Inc.
KING OF PRUSSIA, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results...
Olema_Oncology_HIGH RES LOGO.png
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
May 08, 2024 07:02 ET | Olema Oncology
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
BDgroupRGB.jpg
Black Diamond Group Limited Announces Renewal of Normal Course Issuer Bid
May 08, 2024 07:01 ET | Black Diamond Group Limited
CALGARY, Alberta, May 08, 2024 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (TSX: BDI) (“Black Diamond” or the “Company”) announces that it has obtained approval of the Toronto Stock Exchange...
SpringWorks+400x400px.jpg
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
May 08, 2024 07:00 ET | SpringWorks Therapeutics, Inc.
STAMFORD, Conn., May 08, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today...
sii.png
Sprott Announces First Quarter 2024 Results
May 08, 2024 07:00 ET | Sprott Inc.
TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the quarter ended March 31, 2024. Management commentary...
brinks ® logo_RGB (1).png
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
May 08, 2024 07:00 ET | The Brink’s Company
Record First Quarter Revenue Reflecting 4% Growth and 12% Organic GrowthGAAP net income up 229% to $49M and record adjusted EBITDA up 15% to $218MGAAP EPS up 263% to $1.09 and non-GAAP EPS up 20% to...
GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024
May 08, 2024 07:00 ET | GDS Holdings Limited
SHANGHAI, China, May 08, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data...
Aura_Biosciences_1c_Orange Large.jpg
Aura Biosciences to Participate in Upcoming Investor Conferences
May 08, 2024 07:00 ET | Aura Biosciences, Inc.
BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve...
Bio-Path Logo.jpg
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
May 08, 2024 07:00 ET | Bio-Path Holdings, Inc.
HOUSTON, May 08, 2024 (GLOBE NEWSWIRE) --  Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
Omega_logo1.png
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 08, 2024 07:00 ET | Omega Therapeutics
Programmable epigenomic mRNA candidates enabled durable and robust upregulation of gene expression across a diverse set of gene types and regulatory mechanismsAdditional OMEGA platform capabilities...